A Novel Bcma-Specific, Centyrin-Based CAR-T Product for the Treatment of Multiple Myeloma

被引：17
|
作者：
Hermanson, David L. [1 ]
Barnett, Burton Earle [1 ]
Rengarajan, Srinivas [1 ]
Codde, Rebecca [1 ]
Wang, Xinxin [1 ]
Tan, Yening [1 ]
Martin, Christopher E. [1 ]
Smith, Jenessa Barbara [1 ]
He, Jin [2 ]
Mathur, Rohit [3 ]
Yan, Jing
Neelapu, Sattva S. [4 ]
Osertag, Eric M. [1 ]
Shedlock, Devon J. [1 ]
机构：
[1] Poseida Therapeut, San Diego, CA USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX USA
[3] MD Anderson Canc Ctr, Houston, TX USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX USA
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.2127.2127
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2127
引用
收藏
页数：5
相关论文
共 50 条
  • [31] An alternative fully human anti-BCMA CAR-T shows response for relapsed or refractory multiple myeloma with anti-BCMA CAR-T exposures previously
    Qingming Wang
    Runhong Wei
    Shufang Guo
    Chao Min
    Xiong Zhong
    Hui Huang
    Zhi Cheng
    Cancer Gene Therapy, 2024, 31 : 420 - 426
  • [32] Sequential CD19 and BCMA-specific CAR T-cell treatment elicits sustained remission of relapsed and/or refractory myeloma
    Yan, Lingzhi
    Qu, Su
    Shang, Jingjing
    Shi, Xiaolan
    Kang, Liqing
    Xu, Nan
    Zhu, Mingqing
    Zhou, Jin
    Jin, Song
    Yao, Weiqin
    Yao, Ying
    Chen, Guanghua
    Chang, Huirong
    Zhu, Xiaming
    Yu, Lei
    Wu, Depei
    Fu, Chengcheng
    CANCER MEDICINE, 2021, 10 (02): : 563 - 574
  • [33] A Novel CAR-T cell therapy targeting kappa myeloma antigen for the treatment of multiple myeloma
    Oliaro, Jane
    Li, Jessica
    Haynes, Nicole
    Cummins, Katherine
    Hilton, Halley
    Dunn, Rosanne
    Harrison, Simon
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S41 - S41
  • [34] Cilta-cel, a BCMA-targeting CAR-T therapy for patients with multiple myeloma
    Jagannath, Sundar
    Jackson, Carolyn C.
    Schecter, Jordan M.
    Lendvai, Nikoletta
    Sun, Huabin
    Akram, Muhammad
    Patel, Nitin
    Martin, Thomas G.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2024, 24 (05) : 339 - 350
  • [35] Salvage therapies including retreatment with BCMA-directed approaches after BCMA CAR-T relapses for multiple myeloma
    Reyes, Kevin R.
    Liu, Yen-Chun
    Huang, Chiung-Yu
    Banerjee, Rahul
    Martin, Thomas
    Wong, Sandy W.
    Wolf, Jeffrey L.
    Arora, Shagun
    Shah, Nina
    Chari, Ajai
    Chung, Alfred
    BLOOD ADVANCES, 2024, 8 (09) : 2207 - 2216
  • [36] Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth
    Sun, Fumou
    Cheng, Yan
    Wanchai, Visanu
    Guo, Wancheng
    Mery, David
    Xu, Hongwei
    Gai, Dongzheng
    Siegel, Eric
    Bailey, Clyde
    Ashby, Cody
    Al Hadidi, Samer
    Schinke, Carolina
    Thanendrarajan, Sharmilan
    Ma, Yupo
    Yi, Qing
    Orlowski, Robert Z.
    Zangari, Maurizio
    van Rhee, Frits
    Janz, Siegfried
    Bishop, Gail
    Tricot, Guido
    Shaughnessy, John D.
    Zhan, Fenghuang
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [37] Safety and Efficacy of BCMA-Targeted CAR-T Therapy in Geriatric Patients with Multiple Myeloma
    Reyes, Kevin R.
    Huang, Chiung-Yu
    Lo, Mimi
    Arora, Shagun
    Chung, Alfred
    Wong, Sandy W.
    Wolf, Jeffrey L.
    Martin, Thomas
    Shah, Nina
    Banerjee, Rahul
    BLOOD, 2022, 140 : 5105 - 5107
  • [38] Bispecific Antibodies as Bridging to BCMA CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma
    Fandrei, David
    Seiffert, Sabine
    Rade, Michael
    Rieprecht, Susanne
    Gagelmann, Nico
    Born, Patrick
    Wiemers, Thomas
    Weidner, Heike
    Kreuz, Markus
    Schassberger, Tamara
    Kossmann, Jannik
    Mangold, Marlene
    Fuerst, Daniel
    Fischer, Luise
    Baber, Ronny
    Heyn, Simone
    Wang, Song Yau
    Bach, Enrica
    Hoffmann, Sandra
    Metzeler, Klaus H.
    Herling, Marco
    Jentzsch, Madlen
    Franke, Georg-Nikolaus
    Koehl, Ulrike
    Friedrich, Maik
    Boldt, Andreas
    Reiche, Kristin
    Platzbecker, Uwe
    Vucinic, Vladan
    Merz, Maximilian
    BLOOD CANCER DISCOVERY, 2025, 6 (01): : 38 - 54
  • [39] Early Absolute Lymphocyte Count after BCMA CAR-T as a Surrogate for CAR-T Expansion, Response, and Progression Free Survival in Multiple Myeloma
    Saldarriaga, Mateo Mejia
    Unkenholz, Caitlin
    Pan, Darren
    Mouhieddine, Tarek
    Velez-Hernandez, Juan Esteban
    Engles, Katherine
    Fein, Joshua
    Urrea, Jorge Monge
    Rosenbaum, Cara
    Pearse, Roger
    Jayabalan, David
    Gordillo, Christian
    Chan, Hei Ton
    Yamshon, Samuel
    Thibaud, Santiago
    Mapara, Markus
    Lentzsch, Suzanne
    Inghirami, Girgiio
    Reshef, Ran
    Rossi, Adriana
    Parekh, Samir
    Jagannath, Sundar
    Richard, Shambavi
    Niesvizky, Ruben
    Bustoros, Mark
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S71 - S72
  • [40] Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth
    Fumou Sun
    Yan Cheng
    Visanu Wanchai
    Wancheng Guo
    David Mery
    Hongwei Xu
    Dongzheng Gai
    Eric Siegel
    Clyde Bailey
    Cody Ashby
    Samer Al Hadidi
    Carolina Schinke
    Sharmilan Thanendrarajan
    Yupo Ma
    Qing Yi
    Robert Z. Orlowski
    Maurizio Zangari
    Frits van Rhee
    Siegfried Janz
    Gail Bishop
    Guido Tricot
    John D. Shaughnessy
    Fenghuang Zhan
    Nature Communications, 15
12345